Juli Bollinger
Overview
Explore the profile of Juli Bollinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morain S, Bollinger J, Singleton M, Terkowitz M, Weston C, Sugarman J
J Clin Transl Sci
. 2025 Jan;
9(1):e2.
PMID: 39830605
Introduction: Local context is the most common concern regarding use of a single institutional review board (sIRB). Yet what "local context" constitutes remains underspecified. Developing a shared understanding of the...
2.
Jose S, Bollinger J, Geller G, Greene J, Henry L, Hutler B, et al.
J Law Med Ethics
. 2024 Oct;
52(2):443-455.
PMID: 39435916
Contemporary understanding of the mechanisms of disease increasingly points to examples of "genetic diseases" with an infectious component and of "infectious diseases" with a genetic component. Such blurred boundaries generate...
3.
Schuster A, Folta A, Bollinger J, Geller G, Mehta S, Little S, et al.
Curr Med Res Opin
. 2024 Sep;
40(11):1873-1883.
PMID: 39250177
Objective: HIV molecular epidemiology (HIV ME) is a tool that aims to improve HIV research, surveillance, and cluster detection and response. HIV ME is a core pillar of the U.S....
4.
Morain S, Singleton M, Tsiandoulas K, Bollinger J, Sugarman J
Ethics Hum Res
. 2024 Jun;
46(4):17-26.
PMID: 38944885
A leading concern about single IRB (sIRB) review for multisite studies, as is now required by federal policies, is whether and how sIRBs consider local context in their review. While...
5.
Schuster A, Bollinger J, Geller G, Little S, Mehta S, Sanchez T, et al.
BMC Public Health
. 2024 May;
24(1):1436.
PMID: 38811963
Background: HIV molecular epidemiology (HIV ME) can support the early detection of emerging clusters of new HIV infections by combining HIV sequence data routinely obtained during the clinical treatment of...
6.
Morain S, Bollinger J, Weinfurt K, Sugarman J
Learn Health Syst
. 2024 Jan;
8(1):e10366.
PMID: 38249837
Introduction: Numerous arguments have been advanced for broadly sharing de-identified, participant-level clinical trial data. However, data sharing in pragmatic clinical trials (PCTs) presents ethical challenges. While prior scholarship has described...
7.
Jose S, Geller G, Bollinger J, Mathews D, Kahn J, Garibaldi B
HGG Adv
. 2023 Nov;
5(1):100255.
PMID: 37978805
Several genetic variants linked to COVID-19 have been identified by host genomics researchers. Further advances in this research will likely play a role in the clinical management and public health...
8.
Robinson J, Daoud A, Geary J, Rahimzadeh V, Bollinger J, Guerrini C, et al.
J Law Biosci
. 2023 Jul;
10(2):lsad022.
PMID: 37456713
Sharing cancer gene variant and relevant clinical data could accelerate progress in cancer genomics. However, data sharing is currently impeded by issues related to financial sustainability, equity, incentives, privacy and...
9.
Guerrini C, Majumder M, Robinson J, Cook-Deegan R, Blank M, Bollinger J, et al.
Front Big Data
. 2023 Feb;
6:1095119.
PMID: 36814524
As entities around the world invest in repositories and other infrastructure to facilitate health data sharing, scalable solutions to data sharing challenges are needed. We conducted semi-structured interviews with 24...
10.
Morain S, Bollinger J, Weinfurt K, Sugarman J
Clin Trials
. 2022 Sep;
19(6):681-689.
PMID: 36071689
Numerous arguments have been advanced for broadly sharing de-identified, participant-level clinical trials data, and trial sponsors and journals are increasingly requiring it. However, data sharing in pragmatic clinical trials presents...